Technical analysis of Sutro Biopharma, Inc. (STRO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free protein synthesis with precise, site-specific drug conjugation.
Price Performance
| 1 month | -29.22% |
| 3 months | -47.35% |
| Year-to-date | +34.83% |
| 1 year | +82.88% |
| 3 years | -58.62% |
| 5 years | -92.07% |
52-Week Range
| 52-week High | $43.85 |
| 52-week Low | $7.15 |
| Avg Volume (90d) | 339K |
Technical Indicators
| SMA 50 | $22.60 |
| SMA 200 | $22.56 |
| Beta | 1.31 |
| 30-day Volatility (annualised) | 65.5% |
| Price vs SMA 50 | -31.0% |
| Price vs SMA 200 | -30.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $11.20 | |
| 2025-11 | $9.19 | -17.9% |
| 2025-12 | $11.57 | +25.9% |
| 2026-01 | $14.95 | +29.2% |
| 2026-02 | $20.47 | +36.9% |
| 2026-03 | $24.91 | +21.7% |
| 2026-04 | $36.62 | +47.0% |
| 2026-05 | $29.23 | -20.2% |
| 2026-06 | $33.20 | +13.6% |
| 2026-07 | $24.17 | -27.2% |
| 2026-08 | $20.24 | -16.3% |
| 2026-09 | $15.60 | -22.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $15.60 |
| Market Cap | $151M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -2.10 |
| EV / EBITDA | -0.89 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.10 |
| Current Ratio | 3.32 |